OpenURL Connection Search

Select item for more details and to access through your institution.

A novel prostaglandin I<sub>2</sub> agonist, ONO-1301, attenuates liver inflammation and suppresses fibrosis in non-alcoholic steatohepatitis model mice.
Published in:
Inflammation & Regeneration, 2022, v. 42, n. 1, p. 1, doi. 10.1186/s41232-021-00191-6
By:
- Motegi, Satoko;
- Tsuchiya, Atsunori;
- Iwasawa, Takahiro;
- Sato, Takeki;
- Kumagai, Masaru;
- Natsui, Kazuki;
- Nojiri, Shunsuke;
- Ogawa, Masahiro;
- Takeuchi, Suguru;
- Sakai, Yosiki;
- Miyagawa, Shigeru;
- Sawa, Yoshiki;
- Terai, Shuji
Publication type:
Article
Synthesized HMGB1 peptide attenuates liver inflammation and suppresses fibrosis in mice.
Published in:
Inflammation & Regeneration, 2021, v. 41, n. 1, p. 1, doi. 10.1186/s41232-021-00177-4
By:
- Nojiri, Shunsuke;
- Tsuchiya, Atsunori;
- Natsui, Kazuki;
- Takeuchi, Suguru;
- Watanabe, Takayuki;
- Kojima, Yuichi;
- Watanabe, Yusuke;
- Kamimura, Hiroteru;
- Ogawa, Masahiro;
- Motegi, Satoko;
- Iwasawa, Takahiro;
- Sato, Takeki;
- Kumagai, Masaru;
- Ishii, Yui;
- Kitayama, Tomomi;
- Li, Yu-Tung;
- Ouchi, Yuya;
- Shimbo, Takashi;
- Takamura, Masaaki;
- Tamai, Katsuto
Publication type:
Article
Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases.
Published in:
Inflammation & Regeneration, 2020, v. 40, n. 1, p. 1, doi. 10.1186/s41232-020-00121-y
By:
- Tsuchiya, Atsunori;
- Takeuchi, Suguru;
- Iwasawa, Takahiro;
- Kumagai, Masaru;
- Sato, Takeki;
- Motegi, Satoko;
- Ishii, Yui;
- Koseki, Youhei;
- Tomiyoshi, Kei;
- Natsui, Kazuki;
- Takeda, Nobutaka;
- Yoshida, Yuki;
- Yamazaki, Fusako;
- Kojima, Yuichi;
- Watanabe, Yusuke;
- Kimura, Naruhiro;
- Tominaga, Kentaro;
- Kamimura, Hiroteru;
- Takamura, Masaaki;
- Terai, Shuji
Publication type:
Article
Small extracellular vesicles derived from interferon-γ pre-conditioned mesenchymal stromal cells effectively treat liver fibrosis.
Published in:
NPJ Regenerative Medicine, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41536-021-00132-4
By:
- Takeuchi, Suguru;
- Tsuchiya, Atsunori;
- Iwasawa, Takahiro;
- Nojiri, Shunsuke;
- Watanabe, Takayuki;
- Ogawa, Masahiro;
- Yoshida, Tomoaki;
- Fujiki, Katsunori;
- Koui, Yuta;
- Kido, Taketomo;
- Yoshioka, Yusuke;
- Fujita, Mayu;
- Kikuta, Junichi;
- Itoh, Tohru;
- Takamura, Masaaki;
- Shirahige, Katsuhiko;
- Ishii, Masaru;
- Ochiya, Takahiro;
- Miyajima, Atsushi;
- Terai, Shuji
Publication type:
Article
Antiprogramed cell death‐1 therapy with microspheres for metastatic liver tumors.
Published in:
JGH Open, 2019, v. 3, n. 6, p. 542, doi. 10.1002/jgh3.12213
By:
- Kamimura, Hiroteru;
- Takeda, Nobutaka;
- Owaki, Takashi;
- Mizusawa, Takeshi;
- Iwasawa, Takahiro;
- Ikarashi, Satoshi;
- Hashimoto, Satoru;
- Takamura, Masaaki;
- Terai, Shuji
Publication type:
Article

Found: 5

A novel prostaglandin I<sub>2</sub> agonist, ONO-1301, attenuates liver inflammation and suppresses fibrosis in non-alcoholic steatohepatitis model mice.

Synthesized HMGB1 peptide attenuates liver inflammation and suppresses fibrosis in mice.

Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases.

Small extracellular vesicles derived from interferon-γ pre-conditioned mesenchymal stromal cells effectively treat liver fibrosis.

Antiprogramed cell death‐1 therapy with microspheres for metastatic liver tumors.